Join to View Full Profile
10903 New Hampshire Ave22Silver Spring, MD 20903
Phone+1 615-936-8422
Fax+1 615-343-4977
Dr. Donaldson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Joshua Donaldson, MD is an Oncologist specializing in Breast Cancer based in Silver Spring, MD. His medical journey began at the Sidney Kimmel Medical College at Thomas Jefferson University, where he carried out his Internship and Residency in Internal Medicine. He later undertook his Fellowship in Hematology and Medical Oncology at Johns Hopkins University. His career includes roles at the US Food and Drug Administration as a Medical Officer and as an Instructor at Vanderbilt University Medical Center. He has numerous publications to his name, prominent among them being those in Cancer Discovery, Cancer Research Communications, Oncotarget, Blood Advances, and The Journal of Clinical Investigation. In 2017, he was honored with the Young Investigator Award from the Conquer Cancer Foundation.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2015 - 2019
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2012 - 2015- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 2012 - 2013
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2012
Certifications & Licensure
MD State Medical License 2015 - 2026
TN State Medical License 2019 - 2023
AL State Medical License 2020 - 2020
PA State Medical License 2012 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award Conquer Cancer Foundation, 2017
Publications & Presentations
PubMed
- Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk
Cancer Discovery. 2023-12-12 - 3 citationsPeripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer.Margaret L Axelrod, Yu Wang, Yaomin Xu, Xiaopeng Sun, Cosmin A Bejan
Cancer Research Communications. 2022-05-01 - 3 citationsPEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model.Karen Cravero, Morgan V Pantone, Dong Ho Shin, Riley Bergman, Rory Cochran
Oncotarget. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
